{
  "id": 19170120,
  "title": "Why Pfizer Believes It Can Be a Leader in the GLP-1 Market, Even Though Its Drug May Not Debut Until 2028",
  "url": "https://urgent.news/2026/11/09/why-pfizer-believes-it-can-be-a-leader-in-the-glp-1-market-even",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-09T14:45:02.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/11/09/why-pfizer-believes-it-can-be-a-leader-in-the-glp-1-market-even-though-its-drug-may-not-debut-until-2028/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "Investors shouldn't count out Pfizer in the GLP-1 market just yet.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}